Rxsight Inc

Rxsight Inc(RXST)の財務

$4.990

+0.435 (+8.71%)終値時点

RXST の収益性とマージン

Evaluating the bottom line, RxSight, Inc. maintains a gross margin of 73.62%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -75.32%, while the net margin is -65.99%. These profitability ratios, combined with a Return on Equity (ROE) of -20.10%, provide a clear picture of how effectively RXST converts its operational activities into shareholder value.

RXST の同業比較

In the context of the broader market, RXST competes directly with industry leaders such as SHMD and ESP. With a market capitalization of $190.36M, it holds a leading position in the sector. When comparing efficiency, RXST's gross margin of 73.62% stands against SHMD's 21.24% and ESP's 34.33%. Such benchmarking helps identify whether RxSight, Inc. is trading at a premium or discount relative to its financial performance.

Rxsight Inc の財務パフォーマンス

RxSight has reported a gross margin of 76.72% for Q2 2026, but it is facing significant net losses, with a net loss of $12.1 million and an EPS of -0.29 for the same quarter.

Financials

FY2026Q3
YoY:
-18.97%
24.59M
Total Revenue
FY2026Q3
YoY:
+52.06%
-18.52M
Operating Profit
FY2026Q3
YoY:
+65.28%
-16.22M
Net Income after Tax
FY2026Q2
YoY:
-0.00%
-0.29
EPS - Diluted
FY2026Q3
YoY:
-2591.06%
44.04M
Free Cash Flow
FY2026Q3
YoY:
-7.80%
73.62
Gross Profit Margin - %
FY2026Q3
YoY:
-197.95%
15.30
FCF Margin - %
FY2026Q3
YoY:
+103.99%
-65.99
Net Margin - %
FY2026Q3
-19.71
ROIC

関連記事

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める